Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Estimate the Incidence of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Infants and Young Children in Sub-Saharan Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine

NCT02374450 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02374450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02374450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Estimate the Incidence of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Infants and Young Children in Sub-Saharan Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 5, 2015
Completion date
August 2, 2022
Enrollment
36,366 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malaria